US BROKER MOVES: DG upgraded at HSBC; CRWV upgraded at JPM

UPGRADES Welltower (WELL) upgraded from Neutral to Overweight at JPMorgan; PT USD 260.00 Synopsys (SNPS) upgraded from Underperform to Neutral at BNP Paribas Exane Quanta Services (PWR) upgraded from Market Perform to Outperform at Bernstein SocGen Group; PT USD 775.00 (prev. USD 748.00) Paychex (PAYX) upgraded from Underweight to Neutral at JPMorgan; PT USD 115.00 (prev. USD 105.00) Nebius Group (NBIS) upgraded from Neutral to Outperform at BNP Paribas Exane; PT USD 399.00 (prev. USD 260.00) Macerich (MAC) upgraded from Neutral to Overweight at JPMorgan; PT USD 26.00 EastGroup Properties (EGP) upgraded from Neutral to Overweight at JPMorgan; PT USD 231.00 Dollar General (DG) upgraded from Hold to Buy at HSBC; PT USD 160.00 CoreWeave (CRWV) upgraded from Neutral to Overweight at JPMorgan; PT USD 125.00 Americold Realty Trust (COLD) upgraded from Underweight to Neutral at JPMorgan; PT USD 16.00 Arcturus Therapeutics (ARCT) upgraded from Neutral to Buy at Citi; PT USD 20.00 (prev. USD 8.00) DOWNGRADES Yum! Brands (YUM) downgraded from Buy to Hold at Argus VICI Properties (VICI) downgraded from Overweight to Neutral at JPMorgan; PT USD 30.00 Tanger (SKT) downgraded from Overweight to Neutral at JPMorgan; PT USD 39.00 Stitch Fix (SFIX) downgraded from Outperform to Market Perform at William Blair Safehold (SAFE) downgraded from Neutral to Underweight at JPMorgan; PT USD 14.00 Rollins (ROL) downgraded from Overweight to Neutral at Piper Sandler; PT USD 33.00 (prev. USD 46.00) Kite Realty Group Trust (KRG) downgraded from Neutral to Underweight at JPMorgan; PT USD 27.00 Gaming and Leisure Properties (GLPI) downgraded from Overweight to Neutral at JPMorgan; PT USD 46.00 Etsy (ETSY) downgraded from Buy to Neutral at Arete; PT USD 81.00 Dropbox (DBX) downgraded from Neutral to Sell at Citi; PT USD 29.00 (prev. USD 33.00) Alexandria Real Estate Equities (ARE) downgraded from Neutral to Underweight at JPMorgan; PT USD 56.00 Alkami Technology (ALKT) downgraded from Overweight to Underweight at JPMorgan; PT USD 14.00 (prev. USD 24.00) INITIATIONS Wintrust Financial (WTFC) initiated Equal Weight at Wells Fargo; PT USD 160.00 Versant (VSNT) initiated Buy at Citi; PT USD 41.00 United Therapeutics (UTHR) initiated Sell at Goldman Sachs; PT USD 321.00 Tarsus Pharmaceuticals (TARS) initiated Buy at Goldman Sachs; PT USD 116.00 Sagimet Biosciences (SGMT) initiated Sell at Goldman Sachs; PT USD 7.00 Revolution Medicines (RVMD) initiated Buy at Goldman Sachs; PT USD 267.00 Quince Therapeutics (QNCX) initiated Buy at Rodman & Renshaw; PT USD 70.00 PubMatic (PUBM) initiated Buy at Craig-Hallum; PT USD 24.00 Old National Bancorp (ONB) initiated Overweight at Wells Fargo; PT USD 30.00 MeiraGTx (MGTX) initiated Neutral at Goldman Sachs; PT USD 16.00 MGM Resorts International (MGM) initiated Neutral at BofA Securities; PT USD 40.00 MGE Energy (MGEE) initiated Neutral at BofA Securities; PT USD 76.00 Madrigal Pharmaceuticals (MDGL) initiated Buy at Goldman Sachs; PT USD 704.00 Kymera Therapeutics (KYMR) initiated Early-Stage Biotech at Goldman Sachs Krystal Biotech (KRYS) initiated Buy at Goldman Sachs; PT USD 441.00 Kodiak Sciences (KOD) initiated Neutral at Goldman Sachs; PT USD 36.00 Jazz Pharmaceuticals (JAZZ) initiated Buy at Goldman Sachs; PT USD 337.00 Iovance Biotherapeutics (IOVA) initiated Buy at Goldman Sachs; PT USD 15.00 Insmed (INSM) initiated Buy at Goldman Sachs; PT USD 188.00 IMAX (IMAX) initiated Overweight at Morgan Stanley; PT USD 63.00 Fervo Energy (FRVO) initiated Buy at Johnson Rice; PT USD 35.00 FuelCell Energy (FCEL) initiated Equal Weight at Barclays; PT USD 20.00 Energy Services of America (ESOA) initiated Buy at Roth/MKM; PT USD 20.00 Eupraxia Pharmaceuticals (EPRX) initiated Outperform at Wedbush; PT USD 17.00 California Water Service Group (CWT) initiated Hold at Freedom Broker; PT USD 49.00 Contineum Therapeutics (CTNM) initiated Early-Stage Biotech at Goldman Sachs The Carlyle Group (CG) initiated Overweight at Piper Sandler; PT USD 54.00 CNB Financial (CCNE) initiated Overweight at Piper Sandler; PT USD 38.00 BlueLinx (BXC) initiated Market Perform at Citizens Brink's (BCO) initiated Outperform at Wolfe Research; PT USD 138.00 Arrowhead Pharmaceuticals (ARWR) initiated Neutral at Goldman Sachs; PT USD 74.00 Ares Management (ARES) initiated Overweight at Piper Sandler; PT USD 150.00 Alkermes (ALKS) initiated Neutral at Goldman Sachs; PT USD 50.00 AbCellera Biologics (ABCL) initiated Neutral at Goldman Sachs; PT USD 13.00